id	sid	tid	token	lemma	pos
dpc-3840	1	1	dermatology	dermatology	NOUN
dpc-3840	1	2	:	:	PUNCT
dpc-3840	1	3	practical	practical	ADJ
dpc-3840	1	4	and	and	CCONJ
dpc-3840	1	5	conceptual	conceptual	ADJ
dpc-3840	1	6	letter	letter	NOUN
dpc-3840	1	7	to	to	PART
dpc-3840	1	8	editor	editor	VERB
dpc-3840	1	9	|	|	ADV
dpc-3840	1	10	dermatol	dermatol	ADJ
dpc-3840	1	11	pract	pract	NOUN
dpc-3840	1	12	concept	concept	NOUN
dpc-3840	1	13	.	.	PUNCT
dpc-3840	2	1	2024;14(1):e2024078	2024;14(1):e2024078	NUM
dpc-3840	2	2	1	1	NUM
dpc-3840	2	3	long	long	ADJ
dpc-3840	2	4	-	-	PUNCT
dpc-3840	2	5	term	term	NOUN
dpc-3840	2	6	omalizumab	omalizumab	NOUN
dpc-3840	2	7	use	use	NOUN
dpc-3840	2	8	,	,	PUNCT
dpc-3840	2	9	chronic	chronic	ADJ
dpc-3840	2	10	spontaneous	spontaneous	ADJ
dpc-3840	2	11	 	 	SPACE
dpc-3840	2	12	urticaria	urticaria	NOUN
dpc-3840	2	13	and	and	CCONJ
dpc-3840	2	14	covid-19	covid-19	PROPN
dpc-3840	2	15	öner	öner	NOUN
dpc-3840	2	16	özdemir	özdemir	NOUN
dpc-3840	2	17	division	division	NOUN
dpc-3840	2	18	of	of	ADP
dpc-3840	2	19	allergy	allergy	NOUN
dpc-3840	2	20	and	and	CCONJ
dpc-3840	2	21	immunology	immunology	NOUN
dpc-3840	2	22	,	,	PUNCT
dpc-3840	2	23	department	department	NOUN
dpc-3840	2	24	of	of	ADP
dpc-3840	2	25	pediatrics	pediatric	NOUN
dpc-3840	2	26	,	,	PUNCT
dpc-3840	2	27	research	research	NOUN
dpc-3840	2	28	and	and	CCONJ
dpc-3840	2	29	training	training	NOUN
dpc-3840	2	30	hospital	hospital	NOUN
dpc-3840	2	31	of	of	ADP
dpc-3840	2	32	sakarya	sakarya	NOUN
dpc-3840	2	33	university	university	NOUN
dpc-3840	2	34	medical	medical	ADJ
dpc-3840	2	35	faculty	faculty	NOUN
dpc-3840	2	36	,	,	PUNCT
dpc-3840	2	37	adapazarı	adapazarı	NOUN
dpc-3840	2	38	,	,	PUNCT
dpc-3840	2	39	sakarya	sakarya	NOUN
dpc-3840	2	40	,	,	PUNCT
dpc-3840	2	41	türkiye	türkiye	PROPN
dpc-3840	2	42	citation	citation	NOUN
dpc-3840	2	43	:	:	PUNCT
dpc-3840	2	44	özdemir	özdemir	PROPN
dpc-3840	2	45	ö.	ö.	PROPN
dpc-3840	2	46	long	long	ADJ
dpc-3840	2	47	-	-	PUNCT
dpc-3840	2	48	term	term	NOUN
dpc-3840	2	49	omalizumab	omalizumab	NOUN
dpc-3840	2	50	use	use	NOUN
dpc-3840	2	51	,	,	PUNCT
dpc-3840	2	52	chronic	chronic	ADJ
dpc-3840	2	53	spontaneous	spontaneous	ADJ
dpc-3840	2	54	urticaria	urticaria	NOUN
dpc-3840	2	55	and	and	CCONJ
dpc-3840	2	56	covid-19	covid-19	PROPN
dpc-3840	2	57	.	.	PROPN
dpc-3840	2	58	dermatol	dermatol	PROPN
dpc-3840	2	59	pract	pract	PROPN
dpc-3840	2	60	concept	concept	NOUN
dpc-3840	2	61	.	.	PUNCT
dpc-3840	3	1	2024;14(1):e2024078	2024;14(1):e2024078	X
dpc-3840	3	2	.	.	PUNCT
dpc-3840	4	1	doi	doi	NOUN
dpc-3840	4	2	:	:	PUNCT
dpc-3840	4	3	https://doi.org/10.5826/dpc.1401a78	https://doi.org/10.5826/dpc.1401a78	NOUN
dpc-3840	4	4	accepted	accept	VERB
dpc-3840	4	5	:	:	PUNCT
dpc-3840	4	6	september	september	PROPN
dpc-3840	4	7	24	24	NUM
dpc-3840	4	8	,	,	PUNCT
dpc-3840	4	9	2023	2023	NUM
dpc-3840	4	10	;	;	PUNCT
dpc-3840	4	11	published	publish	VERB
dpc-3840	4	12	:	:	PUNCT
dpc-3840	4	13	january	january	PROPN
dpc-3840	4	14	2024	2024	NUM
dpc-3840	5	1	copyright	copyright	NOUN
dpc-3840	5	2	:	:	PUNCT
dpc-3840	5	3	©	©	PROPN
dpc-3840	5	4	2024	2024	NUM
dpc-3840	5	5	özdemir	özdemir	NOUN
dpc-3840	5	6	.	.	PUNCT
dpc-3840	6	1	this	this	PRON
dpc-3840	6	2	is	be	AUX
dpc-3840	6	3	an	an	DET
dpc-3840	6	4	open	open	ADJ
dpc-3840	6	5	-	-	PUNCT
dpc-3840	6	6	access	access	NOUN
dpc-3840	6	7	article	article	NOUN
dpc-3840	6	8	distributed	distribute	VERB
dpc-3840	6	9	under	under	ADP
dpc-3840	6	10	the	the	DET
dpc-3840	6	11	terms	term	NOUN
dpc-3840	6	12	of	of	ADP
dpc-3840	6	13	the	the	DET
dpc-3840	6	14	creative	creative	ADJ
dpc-3840	6	15	commons	common	NOUN
dpc-3840	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3840	6	17	license	license	NOUN
dpc-3840	6	18	(	(	PUNCT
dpc-3840	6	19	by	by	ADP
dpc-3840	6	20	-	-	PUNCT
dpc-3840	6	21	nc-4.0	nc-4.0	NOUN
dpc-3840	6	22	)	)	PUNCT
dpc-3840	6	23	,	,	PUNCT
dpc-3840	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3840	6	25	,	,	PUNCT
dpc-3840	6	26	which	which	PRON
dpc-3840	6	27	permits	permit	VERB
dpc-3840	6	28	unrestricted	unrestricted	ADJ
dpc-3840	6	29	noncommercial	noncommercial	ADJ
dpc-3840	6	30	use	use	NOUN
dpc-3840	6	31	,	,	PUNCT
dpc-3840	6	32	distribution	distribution	NOUN
dpc-3840	6	33	,	,	PUNCT
dpc-3840	6	34	and	and	CCONJ
dpc-3840	6	35	reproduction	reproduction	NOUN
dpc-3840	6	36	in	in	ADP
dpc-3840	6	37	any	any	DET
dpc-3840	6	38	medium	medium	NOUN
dpc-3840	6	39	,	,	PUNCT
dpc-3840	6	40	provided	provide	VERB
dpc-3840	6	41	the	the	DET
dpc-3840	6	42	original	original	ADJ
dpc-3840	6	43	authors	author	NOUN
dpc-3840	6	44	and	and	CCONJ
dpc-3840	6	45	source	source	NOUN
dpc-3840	6	46	are	be	AUX
dpc-3840	6	47	credited	credit	VERB
dpc-3840	6	48	.	.	PUNCT
dpc-3840	7	1	funding	funding	NOUN
dpc-3840	7	2	:	:	PUNCT
dpc-3840	7	3	none	none	NOUN
dpc-3840	7	4	.	.	PUNCT
dpc-3840	8	1	competing	compete	VERB
dpc-3840	8	2	interests	interest	NOUN
dpc-3840	8	3	:	:	PUNCT
dpc-3840	8	4	none	none	NOUN
dpc-3840	8	5	.	.	PUNCT
dpc-3840	9	1	corresponding	correspond	VERB
dpc-3840	9	2	author	author	NOUN
dpc-3840	9	3	:	:	PUNCT
dpc-3840	9	4	öner	öner	NOUN
dpc-3840	9	5	özdemir	özdemir	PROPN
dpc-3840	9	6	,	,	PUNCT
dpc-3840	9	7	md	md	PROPN
dpc-3840	9	8	,	,	PUNCT
dpc-3840	9	9	division	division	NOUN
dpc-3840	9	10	of	of	ADP
dpc-3840	9	11	allergy	allergy	NOUN
dpc-3840	9	12	and	and	CCONJ
dpc-3840	9	13	immunology	immunology	NOUN
dpc-3840	9	14	,	,	PUNCT
dpc-3840	9	15	department	department	NOUN
dpc-3840	9	16	of	of	ADP
dpc-3840	9	17	pediatrics	pediatric	NOUN
dpc-3840	9	18	,	,	PUNCT
dpc-3840	9	19	faculty	faculty	NOUN
dpc-3840	9	20	of	of	ADP
dpc-3840	9	21	medicine	medicine	NOUN
dpc-3840	9	22	,	,	PUNCT
dpc-3840	9	23	sakarya	sakarya	NOUN
dpc-3840	9	24	university	university	NOUN
dpc-3840	9	25	,	,	PUNCT
dpc-3840	9	26	research	research	NOUN
dpc-3840	9	27	and	and	CCONJ
dpc-3840	9	28	training	training	NOUN
dpc-3840	9	29	hospital	hospital	NOUN
dpc-3840	9	30	of	of	ADP
dpc-3840	9	31	sakarya	sakarya	NOUN
dpc-3840	9	32	university	university	NOUN
dpc-3840	9	33	,	,	PUNCT
dpc-3840	9	34	adnan	adnan	PROPN
dpc-3840	9	35	menderes	menderes	PROPN
dpc-3840	9	36	cad	cad	PROPN
dpc-3840	9	37	.	.	PROPN
dpc-3840	9	38	,	,	PUNCT
dpc-3840	9	39	sağlık	sağlık	PROPN
dpc-3840	9	40	sok	sok	PROPN
dpc-3840	9	41	.	.	PUNCT
dpc-3840	9	42	,	,	PUNCT
dpc-3840	9	43	no	no	INTJ
dpc-3840	9	44	:	:	SYM
dpc-3840	9	45	195	195	NUM
dpc-3840	9	46	,	,	PUNCT
dpc-3840	9	47	adapazarı	adapazarı	NOUN
dpc-3840	9	48	,	,	PUNCT
dpc-3840	9	49	sakarya	sakarya	NOUN
dpc-3840	9	50	,	,	PUNCT
dpc-3840	9	51	turkey	turkey	PROPN
dpc-3840	9	52	.	.	PUNCT
dpc-3840	10	1	tel	tel	ADP
dpc-3840	10	2	:	:	PUNCT
dpc-3840	10	3	+	+	NUM
dpc-3840	10	4	90–(264	90–(264	NUM
dpc-3840	10	5	)	)	PUNCT
dpc-3840	10	6	 	 	SPACE
dpc-3840	11	1	-444	-444	PROPN
dpc-3840	11	2	54	54	NUM
dpc-3840	11	3	00	00	NUM
dpc-3840	11	4	fax	fax	NOUN
dpc-3840	11	5	:	:	PUNCT
dpc-3840	11	6	+90–(264	+90–(264	ADJ
dpc-3840	11	7	)	)	PUNCT
dpc-3840	12	1	-275	-275	PROPN
dpc-3840	12	2	91	91	NUM
dpc-3840	12	3	92	92	NUM
dpc-3840	12	4	e	e	NOUN
dpc-3840	12	5	-	-	NOUN
dpc-3840	12	6	mail	mail	NOUN
dpc-3840	12	7	:	:	PUNCT
dpc-3840	12	8	ozdemir_oner@hotmail.com	ozdemir_oner@hotmail.com	X
dpc-3840	12	9	dear	dear	ADJ
dpc-3840	12	10	editor	editor	NOUN
dpc-3840	12	11	,	,	PUNCT
dpc-3840	12	12	i	i	PRON
dpc-3840	12	13	have	have	AUX
dpc-3840	12	14	read	read	VERB
dpc-3840	12	15	the	the	DET
dpc-3840	12	16	article	article	NOUN
dpc-3840	12	17	titled	title	VERB
dpc-3840	12	18	‘	'	PUNCT
dpc-3840	12	19	long	long	ADJ
dpc-3840	12	20	-	-	PUNCT
dpc-3840	12	21	term	term	NOUN
dpc-3840	12	22	omalizumab	omalizumab	NOUN
dpc-3840	12	23	therapy	therapy	NOUN
dpc-3840	12	24	in	in	ADP
dpc-3840	12	25	patients	patient	NOUN
dpc-3840	12	26	with	with	ADP
dpc-3840	12	27	chronic	chronic	ADJ
dpc-3840	12	28	spontaneous	spontaneous	ADJ
dpc-3840	12	29	urticaria	urticaria	NOUN
dpc-3840	12	30	:	:	PUNCT
dpc-3840	12	31	does	do	AUX
dpc-3840	12	32	it	it	PRON
dpc-3840	12	33	increase	increase	VERB
dpc-3840	12	34	the	the	DET
dpc-3840	12	35	 	 	SPACE
dpc-3840	12	36	risk	risk	NOUN
dpc-3840	12	37	of	of	ADP
dpc-3840	12	38	covid-19	covid-19	PROPN
dpc-3840	12	39	?	?	PUNCT
dpc-3840	12	40	’	'	PUNCT
dpc-3840	12	41	by	by	ADP
dpc-3840	12	42	kaya	kaya	PROPN
dpc-3840	12	43	et	et	PROPN
dpc-3840	12	44	al	al	PROPN
dpc-3840	12	45	with	with	ADP
dpc-3840	12	46	great	great	ADJ
dpc-3840	12	47	interest	interest	NOUN
dpc-3840	13	1	[	[	X
dpc-3840	13	2	1	1	NUM
dpc-3840	13	3	]	]	PUNCT
dpc-3840	13	4	.	.	PUNCT
dpc-3840	14	1	however	however	ADV
dpc-3840	14	2	,	,	PUNCT
dpc-3840	14	3	there	there	PRON
dpc-3840	14	4	are	be	VERB
dpc-3840	14	5	a	a	DET
dpc-3840	14	6	few	few	ADJ
dpc-3840	14	7	points	point	NOUN
dpc-3840	14	8	raised	raise	VERB
dpc-3840	14	9	in	in	ADP
dpc-3840	14	10	my	my	PRON
dpc-3840	14	11	mind	mind	NOUN
dpc-3840	14	12	about	about	ADP
dpc-3840	14	13	the	the	DET
dpc-3840	14	14	study	study	NOUN
dpc-3840	14	15	.	.	PUNCT
dpc-3840	15	1	these	these	PRON
dpc-3840	15	2	are	be	AUX
dpc-3840	15	3	as	as	SCONJ
dpc-3840	15	4	follows	follow	VERB
dpc-3840	15	5	:	:	PUNCT
dpc-3840	15	6	although	although	SCONJ
dpc-3840	15	7	this	this	DET
dpc-3840	15	8	article	article	NOUN
dpc-3840	15	9	mentions	mention	VERB
dpc-3840	15	10	the	the	DET
dpc-3840	15	11	results	result	NOUN
dpc-3840	15	12	of	of	ADP
dpc-3840	15	13	its	its	PRON
dpc-3840	15	14	study	study	NOUN
dpc-3840	15	15	,	,	PUNCT
dpc-3840	15	16	it	it	PRON
dpc-3840	15	17	is	be	AUX
dpc-3840	15	18	a	a	DET
dpc-3840	15	19	major	major	ADJ
dpc-3840	15	20	deficiency	deficiency	NOUN
dpc-3840	15	21	that	that	PRON
dpc-3840	15	22	its	its	PRON
dpc-3840	15	23	results	result	NOUN
dpc-3840	15	24	are	be	AUX
dpc-3840	15	25	not	not	PART
dpc-3840	15	26	discussed	discuss	VERB
dpc-3840	15	27	in	in	ADP
dpc-3840	15	28	the	the	DET
dpc-3840	15	29	light	light	NOUN
dpc-3840	15	30	of	of	ADP
dpc-3840	15	31	the	the	DET
dpc-3840	15	32	recent	recent	ADJ
dpc-3840	15	33	literature	literature	NOUN
dpc-3840	15	34	.	.	PUNCT
dpc-3840	16	1	for	for	ADP
dpc-3840	16	2	instance	instance	NOUN
dpc-3840	16	3	:	:	PUNCT
dpc-3840	16	4	covid-19	covid-19	PROPN
dpc-3840	16	5	can	can	AUX
dpc-3840	16	6	rarely	rarely	ADV
dpc-3840	16	7	exacerbate	exacerbate	VERB
dpc-3840	16	8	csu	csu	VERB
dpc-3840	16	9	,	,	PUNCT
dpc-3840	16	10	even	even	ADV
dpc-3840	16	11	if	if	SCONJ
dpc-3840	16	12	it	it	PRON
dpc-3840	16	13	was	be	AUX
dpc-3840	16	14	not	not	PART
dpc-3840	16	15	seen	see	VERB
dpc-3840	16	16	in	in	ADP
dpc-3840	16	17	this	this	DET
dpc-3840	16	18	study	study	NOUN
dpc-3840	16	19	.	.	PUNCT
dpc-3840	17	1	omalizumab	omalizumab	NOUN
dpc-3840	17	2	(	(	PUNCT
dpc-3840	17	3	omz	omz	PROPN
dpc-3840	17	4	)	)	PUNCT
dpc-3840	17	5	is	be	AUX
dpc-3840	17	6	generally	generally	ADV
dpc-3840	17	7	accepted	accept	VERB
dpc-3840	17	8	as	as	ADV
dpc-3840	17	9	safe	safe	ADJ
dpc-3840	17	10	in	in	ADP
dpc-3840	17	11	adult	adult	NOUN
dpc-3840	17	12	chronic	chronic	ADJ
dpc-3840	17	13	spontaneous	spontaneous	ADJ
dpc-3840	17	14	urticaria	urticaria	NOUN
dpc-3840	17	15	(	(	PUNCT
dpc-3840	17	16	csu	csu	PROPN
dpc-3840	17	17	)	)	PUNCT
dpc-3840	17	18	and	and	CCONJ
dpc-3840	17	19	can	can	AUX
dpc-3840	17	20	be	be	AUX
dpc-3840	17	21	continued	continue	VERB
dpc-3840	17	22	without	without	ADP
dpc-3840	17	23	interruption	interruption	NOUN
dpc-3840	17	24	[	[	X
dpc-3840	17	25	2	2	NUM
dpc-3840	17	26	]	]	PUNCT
dpc-3840	17	27	.	.	PUNCT
dpc-3840	18	1	most	most	ADJ
dpc-3840	18	2	studies	study	NOUN
dpc-3840	18	3	have	have	AUX
dpc-3840	18	4	not	not	PART
dpc-3840	18	5	found	find	VERB
dpc-3840	18	6	an	an	DET
dpc-3840	18	7	association	association	NOUN
dpc-3840	18	8	between	between	ADP
dpc-3840	18	9	omz	omz	NOUN
dpc-3840	18	10	and	and	CCONJ
dpc-3840	18	11	covid-19	covid-19	PROPN
dpc-3840	19	1	[	[	X
dpc-3840	19	2	3	3	NUM
dpc-3840	19	3	]	]	PUNCT
dpc-3840	19	4	.	.	PUNCT
dpc-3840	20	1	therefore	therefore	ADV
dpc-3840	20	2	it	it	PRON
dpc-3840	20	3	is	be	AUX
dpc-3840	20	4	impossible	impossible	ADJ
dpc-3840	20	5	to	to	PART
dpc-3840	20	6	follow	follow	VERB
dpc-3840	20	7	the	the	DET
dpc-3840	20	8	recommendations	recommendation	NOUN
dpc-3840	20	9	proposed	propose	VERB
dpc-3840	20	10	in	in	ADP
dpc-3840	20	11	the	the	DET
dpc-3840	20	12	conclusion	conclusion	NOUN
dpc-3840	20	13	.	.	PUNCT
dpc-3840	21	1	also	also	ADV
dpc-3840	21	2	,	,	PUNCT
dpc-3840	21	3	4/51	4/51	NUM
dpc-3840	21	4	patients	patient	NOUN
dpc-3840	21	5	(	(	PUNCT
dpc-3840	21	6	1	1	NUM
dpc-3840	21	7	inactive	inactive	ADJ
dpc-3840	21	8	,	,	PUNCT
dpc-3840	21	9	3	3	NUM
dpc-3840	21	10	mrna	mrna	NOUN
dpc-3840	21	11	)	)	PUNCT
dpc-3840	21	12	experienced	experience	VERB
dpc-3840	21	13	a	a	DET
dpc-3840	21	14	csu	csu	PROPN
dpc-3840	21	15	flare	flare	NOUN
dpc-3840	21	16	after	after	ADP
dpc-3840	21	17	vaccination	vaccination	NOUN
dpc-3840	21	18	.	.	PUNCT
dpc-3840	22	1	however	however	ADV
dpc-3840	22	2	,	,	PUNCT
dpc-3840	22	3	the	the	DET
dpc-3840	22	4	authors	author	NOUN
dpc-3840	22	5	did	do	AUX
dpc-3840	22	6	not	not	PART
dpc-3840	22	7	discuss	discuss	VERB
dpc-3840	22	8	why	why	SCONJ
dpc-3840	22	9	exacerbations	exacerbation	NOUN
dpc-3840	22	10	occurred	occur	VERB
dpc-3840	22	11	after	after	ADP
dpc-3840	22	12	the	the	DET
dpc-3840	22	13	first	first	ADJ
dpc-3840	22	14	dose	dose	NOUN
dpc-3840	22	15	and	and	CCONJ
dpc-3840	22	16	why	why	SCONJ
dpc-3840	22	17	they	they	PRON
dpc-3840	22	18	were	be	AUX
dpc-3840	22	19	more	more	ADV
dpc-3840	22	20	common	common	ADJ
dpc-3840	22	21	with	with	ADP
dpc-3840	22	22	mrna	mrna	PROPN
dpc-3840	22	23	vaccines	vaccine	NOUN
dpc-3840	22	24	[	[	X
dpc-3840	22	25	4	4	NUM
dpc-3840	22	26	]	]	PUNCT
dpc-3840	22	27	.	.	PUNCT
dpc-3840	23	1	there	there	PRON
dpc-3840	23	2	are	be	VERB
dpc-3840	23	3	some	some	DET
dpc-3840	23	4	contradictory	contradictory	ADJ
dpc-3840	23	5	explanations	explanation	NOUN
dpc-3840	23	6	and	and	CCONJ
dpc-3840	23	7	comments	comment	NOUN
dpc-3840	23	8	[	[	X
dpc-3840	23	9	1	1	NUM
dpc-3840	23	10	]	]	PUNCT
dpc-3840	23	11	.	.	PUNCT
dpc-3840	24	1	after	after	ADP
dpc-3840	24	2	mentioning	mention	VERB
dpc-3840	24	3	that	that	SCONJ
dpc-3840	24	4	omz	omz	NOUN
dpc-3840	24	5	is	be	AUX
dpc-3840	24	6	an	an	DET
dpc-3840	24	7	antiviral	antiviral	NOUN
dpc-3840	24	8	,	,	PUNCT
dpc-3840	24	9	it	it	PRON
dpc-3840	24	10	is	be	AUX
dpc-3840	24	11	supposed	suppose	VERB
dpc-3840	24	12	that	that	SCONJ
dpc-3840	24	13	it	it	PRON
dpc-3840	24	14	increases	increase	VERB
dpc-3840	24	15	the	the	DET
dpc-3840	24	16	sars	sar	NOUN
dpc-3840	24	17	-	-	PUNCT
dpc-3840	24	18	cov-2	cov-2	NOUN
dpc-3840	24	19	infection	infection	NOUN
dpc-3840	24	20	incidence	incidence	NOUN
dpc-3840	24	21	by	by	ADP
dpc-3840	24	22	facilitating	facilitate	VERB
dpc-3840	24	23	intracellular	intracellular	ADJ
dpc-3840	24	24	entry	entry	NOUN
dpc-3840	24	25	through	through	ADP
dpc-3840	24	26	increased	increase	VERB
dpc-3840	24	27	ace-2	ace-2	NUM
dpc-3840	24	28	expression	expression	NOUN
dpc-3840	24	29	[	[	X
dpc-3840	24	30	1	1	NUM
dpc-3840	24	31	]	]	PUNCT
dpc-3840	24	32	.	.	PUNCT
dpc-3840	25	1	but	but	CCONJ
dpc-3840	25	2	would	would	AUX
dpc-3840	25	3	not	not	PART
dpc-3840	25	4	greater	great	ADJ
dpc-3840	25	5	ace-2	ace-2	NUM
dpc-3840	25	6	expression	expression	NOUN
dpc-3840	25	7	also	also	ADV
dpc-3840	25	8	increase	increase	VERB
dpc-3840	25	9	the	the	DET
dpc-3840	25	10	severity	severity	NOUN
dpc-3840	25	11	?	?	PUNCT
dpc-3840	26	1	[	[	X
dpc-3840	26	2	5	5	NUM
dpc-3840	26	3	]	]	PUNCT
dpc-3840	26	4	covid-19	covid-19	PROPN
dpc-3840	26	5	cases	case	NOUN
dpc-3840	26	6	had	have	VERB
dpc-3840	26	7	a	a	DET
dpc-3840	26	8	mild	mild	ADJ
dpc-3840	26	9	course	course	NOUN
dpc-3840	26	10	and	and	CCONJ
dpc-3840	26	11	did	do	AUX
dpc-3840	26	12	not	not	PART
dpc-3840	26	13	cause	cause	VERB
dpc-3840	26	14	exacerbation	exacerbation	NOUN
dpc-3840	26	15	in	in	ADP
dpc-3840	26	16	csu	csu	PROPN
dpc-3840	26	17	.	.	PUNCT
dpc-3840	27	1	it	it	PRON
dpc-3840	27	2	may	may	AUX
dpc-3840	27	3	also	also	ADV
dpc-3840	27	4	not	not	PART
dpc-3840	27	5	be	be	AUX
dpc-3840	27	6	a	a	DET
dpc-3840	27	7	correct	correct	ADJ
dpc-3840	27	8	approach	approach	NOUN
dpc-3840	27	9	to	to	PART
dpc-3840	27	10	attribute	attribute	VERB
dpc-3840	27	11	the	the	DET
dpc-3840	27	12	return	return	NOUN
dpc-3840	27	13	of	of	ADP
dpc-3840	27	14	interrupted	interrupted	ADJ
dpc-3840	27	15	omz	omz	ADJ
dpc-3840	27	16	treatment	treatment	NOUN
dpc-3840	27	17	in	in	ADP
dpc-3840	27	18	risky	risky	ADJ
dpc-3840	27	19	groups	group	NOUN
dpc-3840	27	20	to	to	ADP
dpc-3840	27	21	the	the	DET
dpc-3840	27	22	return	return	NOUN
dpc-3840	27	23	of	of	ADP
dpc-3840	27	24	eosinophil	eosinophil	ADJ
dpc-3840	27	25	count	count	NOUN
dpc-3840	27	26	to	to	ADP
dpc-3840	27	27	pretreatment	pretreatment	NOUN
dpc-3840	27	28	values	value	NOUN
dpc-3840	27	29	[	[	X
dpc-3840	27	30	1	1	NUM
dpc-3840	27	31	]	]	PUNCT
dpc-3840	27	32	.	.	PUNCT
dpc-3840	28	1	because	because	SCONJ
dpc-3840	28	2	it	it	PRON
dpc-3840	28	3	is	be	AUX
dpc-3840	28	4	not	not	PART
dpc-3840	28	5	known	know	VERB
dpc-3840	28	6	whether	whether	SCONJ
dpc-3840	28	7	the	the	DET
dpc-3840	28	8	decrease	decrease	NOUN
dpc-3840	28	9	in	in	ADP
dpc-3840	28	10	eosinophil	eosinophil	ADJ
dpc-3840	28	11	count	count	NOUN
dpc-3840	28	12	in	in	ADP
dpc-3840	28	13	patients	patient	NOUN
dpc-3840	28	14	on	on	ADP
dpc-3840	28	15	omz	omz	NOUN
dpc-3840	28	16	is	be	AUX
dpc-3840	28	17	due	due	ADJ
dpc-3840	28	18	to	to	ADP
dpc-3840	28	19	covid-19	covid-19	PROPN
dpc-3840	28	20	or	or	CCONJ
dpc-3840	28	21	omz	omz	NOUN
dpc-3840	28	22	.	.	PUNCT
dpc-3840	29	1	although	although	SCONJ
dpc-3840	29	2	it	it	PRON
dpc-3840	29	3	is	be	AUX
dpc-3840	29	4	said	say	VERB
dpc-3840	29	5	that	that	SCONJ
dpc-3840	29	6	‘	'	PUNCT
dpc-3840	29	7	none	none	NOUN
dpc-3840	29	8	of	of	ADP
dpc-3840	29	9	the	the	DET
dpc-3840	29	10	other	other	ADJ
dpc-3840	29	11	56	56	NUM
dpc-3840	29	12	patients	patient	NOUN
dpc-3840	29	13	had	have	VERB
dpc-3840	29	14	a	a	DET
dpc-3840	29	15	history	history	NOUN
dpc-3840	29	16	of	of	ADP
dpc-3840	29	17	covid-19	covid-19	PROPN
dpc-3840	29	18	before	before	ADP
dpc-3840	29	19	or	or	CCONJ
dpc-3840	29	20	during	during	ADP
dpc-3840	29	21	omz	omz	ADJ
dpc-3840	29	22	treatment	treatment	NOUN
dpc-3840	29	23	.	.	PUNCT
dpc-3840	29	24	’	'	PUNCT
dpc-3840	29	25	,	,	PUNCT
dpc-3840	29	26	how	how	SCONJ
dpc-3840	29	27	long	long	ADV
dpc-3840	29	28	were	be	AUX
dpc-3840	29	29	they	they	PRON
dpc-3840	29	30	followed	follow	VERB
dpc-3840	29	31	up	up	ADP
dpc-3840	29	32	after	after	SCONJ
dpc-3840	29	33	omz	omz	NOUN
dpc-3840	29	34	stopped	stop	VERB
dpc-3840	29	35	?	?	PUNCT
dpc-3840	30	1	because	because	SCONJ
dpc-3840	30	2	omz	omz	ADJ
dpc-3840	30	3	treatment	treatment	NOUN
dpc-3840	30	4	was	be	AUX
dpc-3840	30	5	longer	long	ADJ
dpc-3840	30	6	in	in	ADP
dpc-3840	30	7	those	those	PRON
dpc-3840	30	8	who	who	PRON
dpc-3840	30	9	had	have	VERB
dpc-3840	30	10	covid-19	covid-19	PROPN
dpc-3840	30	11	than	than	ADP
dpc-3840	30	12	in	in	ADP
dpc-3840	30	13	those	those	PRON
dpc-3840	30	14	who	who	PRON
dpc-3840	30	15	did	do	VERB
dpc-3840	30	16	not	not	PART
dpc-3840	30	17	[	[	X
dpc-3840	30	18	1	1	NUM
dpc-3840	30	19	]	]	PUNCT
dpc-3840	30	20	.	.	PUNCT
dpc-3840	31	1	might	might	AUX
dpc-3840	31	2	omz	omz	ADJ
dpc-3840	31	3	treatment	treatment	NOUN
dpc-3840	31	4	predispose	predispose	VERB
dpc-3840	31	5	to	to	ADP
dpc-3840	31	6	sars	sar	NOUN
dpc-3840	31	7	-	-	PUNCT
dpc-3840	31	8	cov-2	cov-2	PART
dpc-3840	31	9	infection	infection	NOUN
dpc-3840	31	10	,	,	PUNCT
dpc-3840	31	11	especially	especially	ADV
dpc-3840	31	12	even	even	ADV
dpc-3840	31	13	after	after	ADP
dpc-3840	31	14	the	the	DET
dpc-3840	31	15	end	end	NOUN
dpc-3840	31	16	of	of	ADP
dpc-3840	31	17	long	long	ADJ
dpc-3840	31	18	-	-	PUNCT
dpc-3840	31	19	term	term	NOUN
dpc-3840	31	20	use	use	NOUN
dpc-3840	31	21	?	?	PUNCT
dpc-3840	32	1	therefore	therefore	ADV
dpc-3840	32	2	,	,	PUNCT
dpc-3840	32	3	it	it	PRON
dpc-3840	32	4	may	may	AUX
dpc-3840	32	5	be	be	AUX
dpc-3840	32	6	important	important	ADJ
dpc-3840	32	7	to	to	PART
dpc-3840	32	8	answer	answer	VERB
dpc-3840	32	9	this	this	DET
dpc-3840	32	10	question	question	NOUN
dpc-3840	32	11	.	.	PUNCT
dpc-3840	33	1	there	there	PRON
dpc-3840	33	2	are	be	VERB
dpc-3840	33	3	errors	error	NOUN
dpc-3840	33	4	in	in	ADP
dpc-3840	33	5	some	some	DET
dpc-3840	33	6	expressions	expression	NOUN
dpc-3840	33	7	such	such	ADJ
dpc-3840	33	8	as	as	ADP
dpc-3840	33	9	covid-19	covid-19	PROPN
dpc-3840	33	10	infection	infection	NOUN
dpc-3840	33	11	.	.	PUNCT
dpc-3840	34	1	covid-19	covid-19	PROPN
dpc-3840	34	2	is	be	AUX
dpc-3840	34	3	the	the	DET
dpc-3840	34	4	name	name	NOUN
dpc-3840	34	5	of	of	ADP
dpc-3840	34	6	the	the	DET
dpc-3840	34	7	disease	disease	NOUN
dpc-3840	34	8	.	.	PUNCT
dpc-3840	35	1	the	the	DET
dpc-3840	35	2	statement	statement	NOUN
dpc-3840	35	3	of	of	ADP
dpc-3840	35	4	‘	'	PUNCT
dpc-3840	35	5	the	the	DET
dpc-3840	35	6	second	second	ADJ
dpc-3840	35	7	pulmonary	pulmonary	ADJ
dpc-3840	35	8	phase	phase	NOUN
dpc-3840	35	9	’	'	PUNCT
dpc-3840	35	10	is	be	AUX
dpc-3840	35	11	wrong	wrong	ADJ
dpc-3840	35	12	.	.	PUNCT
dpc-3840	36	1	pulmonary	pulmonary	ADJ
dpc-3840	36	2	phase	phase	NOUN
dpc-3840	36	3	is	be	AUX
dpc-3840	36	4	the	the	DET
dpc-3840	36	5	second	second	ADJ
dpc-3840	36	6	phase	phase	NOUN
dpc-3840	36	7	of	of	ADP
dpc-3840	36	8	covid-19	covid-19	PROPN
dpc-3840	36	9	.	.	PUNCT
dpc-3840	37	1	in	in	ADP
dpc-3840	37	2	table	table	NOUN
dpc-3840	37	3	1	1	NUM
dpc-3840	37	4	,	,	PUNCT
dpc-3840	37	5	after	after	ADP
dpc-3840	37	6	‘	'	PUNCT
dpc-3840	37	7	number	number	NOUN
dpc-3840	37	8	of	of	ADP
dpc-3840	37	9	patients	patient	NOUN
dpc-3840	37	10	’	'	PUNCT
dpc-3840	37	11	,	,	PUNCT
dpc-3840	37	12	n	n	PRON
dpc-3840	37	13	is	be	AUX
dpc-3840	37	14	not	not	PART
dpc-3840	37	15	meaningless	meaningless	ADJ
dpc-3840	37	16	there	there	ADV
dpc-3840	37	17	.	.	PUNCT
dpc-3840	38	1	n	n	PRON
dpc-3840	38	2	should	should	AUX
dpc-3840	38	3	have	have	AUX
dpc-3840	38	4	been	be	AUX
dpc-3840	38	5	used	use	VERB
dpc-3840	38	6	always	always	ADV
dpc-3840	38	7	as	as	ADP
dpc-3840	38	8	a	a	DET
dpc-3840	38	9	capital	capital	NOUN
dpc-3840	38	10	letter	letter	NOUN
dpc-3840	38	11	,	,	PUNCT
dpc-3840	38	12	not	not	PART
dpc-3840	38	13	lowercase	lowercase	ADJ
dpc-3840	38	14	(	(	PUNCT
dpc-3840	38	15	n	n	CCONJ
dpc-3840	38	16	)	)	PUNCT
dpc-3840	38	17	.	.	PUNCT
dpc-3840	39	1	2	2	NUM
dpc-3840	39	2	letter	letter	NOUN
dpc-3840	39	3	to	to	PART
dpc-3840	39	4	editor	editor	VERB
dpc-3840	39	5	|	|	ADV
dpc-3840	39	6	dermatol	dermatol	ADJ
dpc-3840	39	7	pract	pract	NOUN
dpc-3840	39	8	concept	concept	NOUN
dpc-3840	39	9	.	.	PUNCT
dpc-3840	40	1	2024;14(1):e2024078	2024;14(1):e2024078	NUM
dpc-3840	40	2	references	reference	NOUN
dpc-3840	40	3	1	1	NUM
dpc-3840	40	4	.	.	PUNCT
dpc-3840	41	1	kaya	kaya	PROPN
dpc-3840	41	2	ö	ö	PROPN
dpc-3840	41	3	,	,	PUNCT
dpc-3840	41	4	keskinkaya	keskinkaya	PROPN
dpc-3840	41	5	z	z	PROPN
dpc-3840	41	6	,	,	PUNCT
dpc-3840	41	7	işık	işık	ADJ
dpc-3840	41	8	mermutlu	mermutlu	PROPN
dpc-3840	41	9	s	s	PART
dpc-3840	41	10	,	,	PUNCT
dpc-3840	41	11	oğuz	oğuz	PROPN
dpc-3840	41	12	kılıç	kılıç	PROPN
dpc-3840	41	13	s	s	PROPN
dpc-3840	41	14	,	,	PUNCT
dpc-3840	41	15	öztürk	öztürk	PROPN
dpc-3840	41	16	 	 	SPACE
dpc-3840	41	17	s.	s.	PROPN
dpc-3840	41	18	long	long	ADJ
dpc-3840	41	19	-	-	PUNCT
dpc-3840	41	20	term	term	NOUN
dpc-3840	41	21	omalizumab	omalizumab	NOUN
dpc-3840	41	22	therapy	therapy	NOUN
dpc-3840	41	23	in	in	ADP
dpc-3840	41	24	patients	patient	NOUN
dpc-3840	41	25	with	with	ADP
dpc-3840	41	26	chronic	chronic	ADJ
dpc-3840	41	27	spontaneous	spontaneous	ADJ
dpc-3840	41	28	urticaria	urticaria	NOUN
dpc-3840	41	29	:	:	PUNCT
dpc-3840	41	30	does	do	AUX
dpc-3840	41	31	it	it	PRON
dpc-3840	41	32	increase	increase	VERB
dpc-3840	41	33	the	the	DET
dpc-3840	41	34	risk	risk	NOUN
dpc-3840	41	35	of	of	ADP
dpc-3840	41	36	covid-19	covid-19	PROPN
dpc-3840	41	37	?	?	PUNCT
dpc-3840	41	38	dermatol	dermatol	NOUN
dpc-3840	41	39	pract	pract	PROPN
dpc-3840	41	40	concept	concept	NOUN
dpc-3840	41	41	.	.	PUNCT
dpc-3840	42	1	2023;13(3):e2023145	2023;13(3):e2023145	NUM
dpc-3840	42	2	.	.	PUNCT
dpc-3840	43	1	doi	doi	NOUN
dpc-3840	43	2	:	:	PUNCT
dpc-3840	43	3	10.5826	10.5826	NUM
dpc-3840	43	4	/dpc.1303a145	/dpc.1303a145	PROPN
dpc-3840	43	5	.	.	PUNCT
dpc-3840	44	1	pmid	pmid	NOUN
dpc-3840	44	2	:	:	PUNCT
dpc-3840	44	3	37557113	37557113	NUM
dpc-3840	44	4	.	.	PUNCT
dpc-3840	45	1	pmcid	pmcid	ADJ
dpc-3840	45	2	:	:	PUNCT
dpc-3840	45	3	pmc10412006	pmc10412006	NOUN
dpc-3840	45	4	.	.	PUNCT
dpc-3840	46	1	2	2	X
dpc-3840	46	2	.	.	X
dpc-3840	46	3	özdemir	özdemir	PROPN
dpc-3840	46	4	ö.	ö.	PROPN
dpc-3840	46	5	omalizumab	omalizumab	PROPN
dpc-3840	46	6	’s	’s	PART
dpc-3840	46	7	efficacy	efficacy	NOUN
dpc-3840	46	8	and	and	CCONJ
dpc-3840	46	9	safety	safety	NOUN
dpc-3840	46	10	against	against	ADP
dpc-3840	46	11	chronic	chronic	ADJ
dpc-3840	46	12	spontaneous	spontaneous	ADJ
dpc-3840	46	13	urticaria	urticaria	NOUN
dpc-3840	46	14	.	.	PUNCT
dpc-3840	47	1	world	world	PROPN
dpc-3840	47	2	allergy	allergy	PROPN
dpc-3840	47	3	organ	organ	PROPN
dpc-3840	47	4	j.	j.	PROPN
dpc-3840	47	5	2023;16(8):100808	2023;16(8):100808	PROPN
dpc-3840	47	6	.	.	PUNCT
dpc-3840	48	1	doi	doi	NOUN
dpc-3840	48	2	:	:	PUNCT
dpc-3840	48	3	10.1016	10.1016	NUM
dpc-3840	48	4	/	/	SYM
dpc-3840	48	5	j.waojou.2023.100808	j.waojou.2023.100808	NOUN
dpc-3840	48	6	.	.	PUNCT
dpc-3840	49	1	pmid	pmid	NOUN
dpc-3840	49	2	:	:	PUNCT
dpc-3840	49	3	37638362	37638362	NUM
dpc-3840	49	4	.	.	PUNCT
dpc-3840	50	1	pmcid	pmcid	NOUN
dpc-3840	50	2	:	:	PUNCT
dpc-3840	50	3	pmc10458888	pmc10458888	PROPN
dpc-3840	50	4	.	.	PUNCT
dpc-3840	51	1	3	3	X
dpc-3840	51	2	.	.	X
dpc-3840	51	3	bostan	bostan	PROPN
dpc-3840	51	4	e	e	PROPN
dpc-3840	51	5	,	,	PUNCT
dpc-3840	51	6	zaid	zaid	PROPN
dpc-3840	51	7	f	f	PROPN
dpc-3840	51	8	,	,	PUNCT
dpc-3840	51	9	karaduman	karaduman	PROPN
dpc-3840	51	10	a	a	PROPN
dpc-3840	51	11	,	,	PUNCT
dpc-3840	51	12	et	et	PROPN
dpc-3840	51	13	al	al	PROPN
dpc-3840	51	14	.	.	PUNCT
dpc-3840	52	1	the	the	DET
dpc-3840	52	2	effect	effect	NOUN
dpc-3840	52	3	of	of	ADP
dpc-3840	52	4	covid-19	covid-19	PROPN
dpc-3840	52	5	on	on	ADP
dpc-3840	52	6	patients	patient	NOUN
dpc-3840	52	7	with	with	ADP
dpc-3840	52	8	chronic	chronic	ADJ
dpc-3840	52	9	spontaneous	spontaneous	ADJ
dpc-3840	52	10	urticaria	urticaria	NOUN
dpc-3840	52	11	treated	treat	VERB
dpc-3840	52	12	with	with	ADP
dpc-3840	52	13	omalizumab	omalizumab	NOUN
dpc-3840	52	14	and	and	CCONJ
dpc-3840	52	15	antihistamines	antihistamine	VERB
dpc-3840	52	16	:	:	PUNCT
dpc-3840	52	17	a	a	DET
dpc-3840	52	18	cross	cross	ADJ
dpc-3840	52	19	-	-	ADJ
dpc-3840	52	20	sectional	sectional	ADJ
dpc-3840	52	21	,	,	PUNCT
dpc-3840	52	22	comparative	comparative	ADJ
dpc-3840	52	23	study	study	NOUN
dpc-3840	52	24	.	.	PUNCT
dpc-3840	53	1	j	j	PROPN
dpc-3840	53	2	cosmet	cosmet	PROPN
dpc-3840	53	3	dermatol	dermatol	NOUN
dpc-3840	53	4	.	.	PUNCT
dpc-3840	54	1	2021;20(11):3369	2021;20(11):3369	PROPN
dpc-3840	54	2	-	-	SYM
dpc-3840	54	3	3375	3375	NUM
dpc-3840	54	4	.	.	PUNCT
dpc-3840	55	1	doi	doi	NOUN
dpc-3840	55	2	:	:	PUNCT
dpc-3840	55	3	10.1111	10.1111	NUM
dpc-3840	55	4	/	/	SYM
dpc-3840	55	5	jocd.14484	jocd.14484	PROPN
dpc-3840	55	6	.	.	PUNCT
dpc-3840	56	1	pmid	pmid	NOUN
dpc-3840	56	2	:	:	PUNCT
dpc-3840	56	3	34599630	34599630	NUM
dpc-3840	56	4	.	.	PUNCT
dpc-3840	57	1	pmcid	pmcid	NOUN
dpc-3840	57	2	:	:	PUNCT
dpc-3840	57	3	pmc8661558	pmc8661558	PROPN
dpc-3840	57	4	.	.	PUNCT
dpc-3840	58	1	4	4	X
dpc-3840	58	2	.	.	X
dpc-3840	58	3	özdemir	özdemir	PROPN
dpc-3840	58	4	ö.	ö.	PROPN
dpc-3840	58	5	might	might	AUX
dpc-3840	58	6	chronic	chronic	VERB
dpc-3840	58	7	spontaneous	spontaneous	ADJ
dpc-3840	58	8	urticaria	urticaria	NOUN
dpc-3840	58	9	develop	develop	VERB
dpc-3840	58	10	after	after	ADP
dpc-3840	58	11	sars	sar	NOUN
dpc-3840	58	12	-	-	PUNCT
dpc-3840	58	13	cov-2	cov-2	NOUN
dpc-3840	58	14	vaccinations	vaccination	NOUN
dpc-3840	58	15	?	?	PUNCT
dpc-3840	59	1	eur	eur	PROPN
dpc-3840	59	2	j	j	PROPN
dpc-3840	59	3	clin	clin	PROPN
dpc-3840	59	4	pharmacol	pharmacol	PROPN
dpc-3840	59	5	.	.	PUNCT
dpc-3840	60	1	2023	2023	NUM
dpc-3840	60	2	;	;	PUNCT
dpc-3840	61	1	79(9):1279	79(9):1279	NUM
dpc-3840	61	2	-	-	SYM
dpc-3840	61	3	1280	1280	NUM
dpc-3840	61	4	.	.	PUNCT
dpc-3840	62	1	doi	doi	NOUN
dpc-3840	62	2	:	:	PUNCT
dpc-3840	62	3	10.1007	10.1007	NUM
dpc-3840	62	4	/	/	SYM
dpc-3840	62	5	s00228	s00228	PROPN
dpc-3840	62	6	-	-	PUNCT
dpc-3840	62	7	023	023	NUM
dpc-3840	62	8	-	-	PUNCT
dpc-3840	62	9	03532	03532	NUM
dpc-3840	62	10	-	-	SYM
dpc-3840	62	11	1	1	NUM
dpc-3840	62	12	.	.	PUNCT
dpc-3840	63	1	pmid	pmid	NOUN
dpc-3840	63	2	:	:	PUNCT
dpc-3840	63	3	37393210	37393210	NUM
dpc-3840	63	4	.	.	PUNCT
dpc-3840	64	1	5	5	X
dpc-3840	64	2	.	.	X
dpc-3840	64	3	ashraf	ashraf	PROPN
dpc-3840	64	4	um	um	INTJ
dpc-3840	64	5	,	,	PUNCT
dpc-3840	64	6	abokor	abokor	PROPN
dpc-3840	64	7	aa	aa	PROPN
dpc-3840	64	8	,	,	PUNCT
dpc-3840	64	9	edwards	edwards	PROPN
dpc-3840	64	10	jm	jm	PROPN
dpc-3840	64	11	,	,	PUNCT
dpc-3840	64	12	et	et	PROPN
dpc-3840	64	13	al	al	PROPN
dpc-3840	64	14	.	.	PUNCT
dpc-3840	65	1	sars	sars	PROPN
dpc-3840	65	2	-	-	PUNCT
dpc-3840	65	3	cov-2	cov-2	NOUN
dpc-3840	65	4	,	,	PUNCT
dpc-3840	65	5	ace2	ace2	NOUN
dpc-3840	65	6	expression	expression	NOUN
dpc-3840	65	7	,	,	PUNCT
dpc-3840	65	8	and	and	CCONJ
dpc-3840	65	9	systemic	systemic	ADJ
dpc-3840	65	10	organ	organ	NOUN
dpc-3840	65	11	invasion	invasion	NOUN
dpc-3840	65	12	.	.	PUNCT
dpc-3840	66	1	physiol	physiol	PROPN
dpc-3840	66	2	genomics	genomics	PROPN
dpc-3840	66	3	.	.	PUNCT
dpc-3840	67	1	2021;53(2):51	2021;53(2):51	NUM
dpc-3840	67	2	-	-	SYM
dpc-3840	67	3	60	60	NUM
dpc-3840	67	4	.	.	PUNCT
dpc-3840	68	1	doi	doi	NOUN
dpc-3840	68	2	:	:	PUNCT
dpc-3840	68	3	10.1152	10.1152	NUM
dpc-3840	68	4	/	/	SYM
dpc-3840	68	5	physiolgenomics.00087.2020	physiolgenomics.00087.2020	NOUN
dpc-3840	68	6	.	.	PUNCT
dpc-3840	69	1	pmid	pmid	NOUN
dpc-3840	69	2	:	:	PUNCT
dpc-3840	69	3	33275540	33275540	NUM
dpc-3840	69	4	.	.	PUNCT
dpc-3840	70	1	pmcid	pmcid	NOUN
dpc-3840	70	2	:	:	PUNCT
dpc-3840	70	3	pmc7900915	pmc7900915	ADJ
dpc-3840	70	4	.	.	PUNCT